Gennex Laboratories Ltd

Gennex Lab. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Gennex Laboratories Ltd

₹ 13.1 0.23%
11 Jun - close price
gennexlab.com BSE: 531739
About

Incorporated in 1995, Gennex Laboratories Ltd manufactures Bulk Drugs and Intermediaries[1]

Key Points

Business Overview:[1][2]
GLL is an ISO 9001:2008, TUV, ISO 14001 and OSHAS 18000 certified vertically integrated Active Pharmaceutical Ingredient manufacturer & exporter of Bulk Drugs, Intermediates and Biotech Products in the form of Expectorants,
Muscle Relaxants, Analgesic and Anti Fungal, etc.

Website BSE
  • Market Cap ₹ 298 Cr.
  • Current Price ₹ 13.1
  • High / Low ₹ 29.0 / 11.2
  • Stock P/E 18.5
  • Book Value ₹ 8.21
  • Dividend Yield 0.00 %
  • ROCE 12.5 %
  • ROE 9.03 %
  • Face Value ₹ 1.00
Edit ratios

Pros

  • Company is expected to give good quarter
  • Company has delivered good profit growth of 55.4% CAGR over last 5 years
  • Debtor days have improved from 54.1 to 34.8 days.

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • Promoter holding is low: 18.4%
  • Company has a low return on equity of 9.21% over last 3 years.
  • Promoter holding has decreased over last 3 years: -3.63%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
21.22 14.51 19.62 14.63 20.80 16.52 18.18 21.39 35.52 30.79 33.38 40.01 44.16
19.39 13.06 17.76 12.81 17.28 11.42 12.41 16.59 29.26 24.10 25.92 32.86 38.31
Operating Profit 1.83 1.45 1.86 1.82 3.52 5.10 5.77 4.80 6.26 6.69 7.46 7.15 5.85
OPM % 8.62% 9.99% 9.48% 12.44% 16.92% 30.87% 31.74% 22.44% 17.62% 21.73% 22.35% 17.87% 13.25%
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Interest 0.20 0.26 0.10 0.19 0.63 0.73 0.78 0.83 0.73 0.73 0.22 0.84 1.20
Depreciation 0.34 0.18 0.36 0.18 0.37 0.65 1.03 0.45 0.23 0.45 1.11 0.50 0.54
Profit before tax 1.29 1.01 1.40 1.45 2.52 3.72 3.96 3.52 5.30 5.51 6.13 5.81 4.11
Tax % 16.28% 24.75% 25.00% 24.83% 19.05% 23.39% 22.47% 21.31% 15.28% 15.43% 12.23% 12.91% 25.06%
1.07 0.75 1.05 1.08 2.04 2.85 3.07 2.76 4.50 4.66 5.38 5.06 3.07
EPS in Rs 0.06 0.04 0.06 0.07 0.12 0.16 0.17 0.15 0.20 0.20 0.21 0.20 0.10
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
42 44 56 56 60 61 66 87 148
37 42 52 52 53 56 61 70 121
Operating Profit 5 2 4 3 7 5 5 17 27
OPM % 11% 5% 7% 6% 11% 9% 7% 20% 18%
0 1 1 1 0 1 4 5 0
Interest 1 1 1 1 1 1 1 3 4
Depreciation 1 1 1 1 1 1 1 2 2
Profit before tax 3 1 3 3 5 5 6 16 22
Tax % 13% 42% 26% 27% 20% 23% 23% 20% 16%
3 1 2 2 4 4 5 13 18
EPS in Rs 0.14 0.04 0.12 0.10 0.21 0.21 0.28 0.58 0.71
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: 22%
3 Years: 34%
TTM: 71%
Compounded Profit Growth
10 Years: %
5 Years: 55%
3 Years: 60%
TTM: 27%
Stock Price CAGR
10 Years: 23%
5 Years: 27%
3 Years: 26%
1 Year: -17%
Return on Equity
10 Years: %
5 Years: 9%
3 Years: 9%
Last Year: 9%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 13 13 13 13 13 13 18 23 23
Reserves 18 19 21 23 27 31 62 148 164
4 2 5 5 7 10 1 6 27
14 16 13 16 12 14 51 54 42
Total Liabilities 49 50 52 57 59 68 132 230 256
16 16 16 15 14 14 74 56 60
CWIP 0 0 0 0 0 0 0 2 5
Investments 7 7 7 7 7 7 0 0 0
26 28 29 35 38 48 59 172 191
Total Assets 49 50 52 57 59 68 132 230 256

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
-0 3 2 -2 -1 12 24 -47 -11
-1 -1 -1 -0 -0 -2 -38 19 1
1 -2 1 -0 2 -2 21 74 5
Net Cash Flow -0 0 2 -2 0 8 6 46 -5

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 90 87 68 41 55 67 52 75 35
Inventory Days 43 31 57 78 50 72 139 184 135
Days Payable 139 161 88 86 59 72 63 111 49
Cash Conversion Cycle -7 -43 38 34 46 67 129 148 120
Working Capital Days 106 93 86 119 153 148 29 279 224
ROCE % 6% 11% 8% 14% 12% 11% 14% 12%

Shareholding Pattern

Numbers in percentages

Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
22.05% 23.38% 23.38% 23.38% 23.38% 23.61% 23.61% 18.41% 18.41% 18.41% 18.41% 18.41%
77.95% 76.63% 76.62% 76.62% 76.62% 76.39% 76.39% 81.58% 81.57% 81.59% 81.58% 81.58%
No. of Shareholders 57,87759,17258,24855,60952,98150,98869,72383,99687,82090,23692,50692,326

Documents

Announcements

Annual reports

Right Issue